STOCK TITAN

Myomo: Rosalind Master Fund reports roughly 9.77% stake

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

MYOMO, Inc. (MYO) common shares are the subject of an amended ownership report by Rosalind Advisors, Inc., Rosalind Master Fund L.P. (RMF), portfolio manager Steven Salamon and reporting person Gilad Aharon. The cover pages list 7,681,144 shares as aggregate beneficially owned, including 3,917,886 common shares and 3,763,258 shares issuable upon exercise of pre-funded warrants; the reported aggregate does not give effect to warrant blockers.

RMF states its 3,917,886 common shares represent approximately 9.77% of the common stock, using 40,099,174 shares outstanding as of November 3, 2026. The reporting persons said no warrants could be exercised as of September 30, 2026, because of a blocker limiting exercise that would result in beneficial ownership above 9.99%. Rosalind Advisors and Salamon disclaim beneficial ownership.

Aggregate beneficial ownership shown on cover 7,681,144 shares Cover-page figure includes warrant shares and does not give effect to blocker provisions.
Common shares 3,917,886 shares RMF may be deemed beneficial owner; stated as approximately 9.77% of common stock.
Shares issuable upon exercise of pre-funded warrants 3,763,258 shares The reporting persons said no warrants could be exercised as of September 30, 2026, because of blockers.
Common shares outstanding 40,099,174 shares As of November 3, 2026.
Beneficial ownership blocker 9.99% Warrant exercise is restricted to the extent it would result in beneficial ownership above this level.
pre-funded warrants financial
"shares issuable upon exercise of pre-funded warrants"
Pre-funded warrants are financial instruments that give investors the right to purchase a company's stock at a set price, but with most or all of the purchase price paid upfront. They function like a coupon or gift card for stock, allowing investors to buy shares later at a fixed price, which can be beneficial if they want to avoid future price increases. This makes them important for investors seeking flexibility and certainty in their investment plans.
blocker provision regulatory
"blocker provision under which the holder does not have the right to exercise"
beneficial ownership regulatory
"actual number of shares of Common Stock beneficially owned"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MYO shares did Rosalind Master Fund report?

Rosalind Master Fund L.P. reported 3,917,886 common shares, approximately 9.77% of the common stock, and separately listed 3,763,258 shares issuable upon exercise of pre-funded warrants. The cover pages list 7,681,144 shares in aggregate, but state that this figure does not give effect to warrant blockers.

Why could the MYO pre-funded warrants not be exercised?

The warrants include a blocker that prevents exercise to the extent it would result in beneficial ownership above 9.99% of common stock. RMF said no warrants could be exercised as of September 30, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google





62857J201

(CUSIP Number)
09/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth in Row 11 of the cover page for each Reporting Person is based upon 40,099,174 shares of the Issuer's common stock outstanding as of November 3rd, 2026, in accordance with the 10Q filed by the issuer on November 9th. However, as more fully described in Item 4, the securities reported in rows (6), (8), and (9) show the number of shares of Common Stock that would be issuable upon exercise of such reported securities and do not give effect to blocker provisions. Therefore, the actual number of shares of Common Stock beneficially owned by such Reporting Person, after giving effect to such blockers, is less than the number of securities reported in rows (6), (8), and (9). (6) 3,917,886 shares of Common Stock 3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 3,917,886 shares of Common Stock 3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 3,917,886 shares of Common Stock 3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G




Comment for Type of Reporting Person: (6) 3,917,886 shares of Common Stock 3,763,258 shares of Common Stock issuable upon exercise of pre-funded warrants


SCHEDULE 13G



Rosalind Advisors, Inc.
Signature:Steven Salamon
Name/Title:President
Date:11/12/2026
SALAMON STEVEN A J
Signature:Steven Salamon
Name/Title:Steven Salamon
Date:11/12/2026
Aharon Gil
Signature:Gil Aharon
Name/Title:Gil Aharon
Date:11/12/2026
Rosalind Master Fund L.P.
Signature:Mike McDonald
Name/Title:Director, Rosalind (Cayman) Ltd. (as General Partner to Rosalind Master Fund)
Date:11/12/2026

Keep reading